Barr To Pay $142M To Settle Patent Dispute With Organon

Law360, New York (September 8, 2005, 12:00 AM EDT) -- U.S. drug maker Barr Pharmaceuticals will pay Dutch rival Organon International $142 million to settle a patent lawsuit over a generic version of the oral contraceptive Mircette.

Organon, a subsidiary of Dutch industrial conglomerate Akzo Nobel, and Duramed Pharmaceuticals Inc., a subsidiary of Barr Pharmaceuticals, have signed a non-binding letter of intent to settle the pending patent lawsuit concerning a generic version of Mircette, the two companies said in a statement.

Under the terms of the agreement, Barr Pharmaceuticals will acquire all rights relating to Mircette,...
To view the full article, register now.